Twitter Beğeni Hilesi

🧬 really looking forward to this event with my fabulous colleague Allison Kurian All about achieving the best collaborative science to improve early detection and prevention for families with hereditary cancer risk, and the insights gained for sporadic cancers. Do join us 🧬

Allison Kurian and I had a fabulous discussion. Thank you to Allison, and Eleanor and Steph Ng for organising, and ACED for hosting. All about delivering the very best science we can to improve outcomes for patients and families 🧬

Excited to see our paper on antibiotics and triple-negative breast cancer mortality just published in Nature Communications: rdcu.be/c9Nkz.

And here is our blog post: cancercommunity.nature.com/posts/antimicr….

A press release on our recent study: med.stanford.edu/news/all-news/…

It is a glorious day in Chicago ECOG-ACRIN Cancer Research Group spring 2023 meeting. So proud of Stanford Cancer Institute Stanford Department of Medicine oncology fellow Dr Julia Ransohoff for winning the 2023 Paul Carbone, MD Fellowship Award. Congratulations!!

Congratulations to the 2023 Paul Carbone, MD Fellowship Award recipient, Julia D. Ransohoff, MD of Stanford Medicine Stanford Health Care #TripleNegative #BreastCancer #TNBC #EAonc #mentorship #bcsm

Among patients diagnosed with cancer in Georgia and California between 2013 and 2019, only 6.8% underwent germline testing. #ASCO23 ja.ma/42tlfxo

Germline Genetic Testing After Cancer Diagnosis | Breast Cancer | JAMA | JAMA Network jamanetwork.com/journals/jama/…

A privilege to present our work on genetic testing after cancer diagnosis at ASCO today, with simultaneous JAMA publication.

DNA sequencing improves cancer treatment but remains underused. Why? usatoday.com/story/news/hea…

In 1995, Allison Walsh Allison Kurian, Rachel Rosovsky and I matriculated to med school together Harvard Medical School. Today, we were listed as the authors of 3 most read research papers in JAMA this week—how cool is that?! Go Class of ‘99! #MedTwitter MassGeneral News

Another recent article that makes JAMA Most Viewed list “Germline Genetic Testing After Cancer Diagnosis” Allison Kurian & colleagues - published with ASCO meeting jamanetwork.com/journals/jama/…

Our new paper reveals US payers’ barriers, opportunities for coverage of MCED, promising but controversial tests for multicancer early detection Health Affairs #HAScholar Kathryn A Phillips PhD Allison Kurian Christine Weldon Michael Douglas academic.oup.com/healthaffairss…

Meeting the need for germline testing - The Lancet Oncology thelancet.com/journals/lanon…

Based on 4 simulation models, breast cancer screening, treatment of stage I to III breast cancer, and treatment of metastatic breast cancer were associated with reduced breast cancer mortality between 1975 and 2019 in the US. ja.ma/47EB7zR

Deaths from breast cancer dropped 58% between 1975 and 2019 due to a combination of screening mammography and improvements in treatment, according to a new study led by Stanford Medicine clinicians and biomedical data scientists. #BreastCancer #DataScience stan.md/3Ougj7x

I am so happy to see this major collaborative effort published Stanford Plevritis Lab Allison Kurian (and Liyang Sun!) and wanted to share some of my thoughts having worked on it.